YOUSIF CAPITAL MANAGEMENT, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1858789
BLOOMFIELD HILLS, MI
Position in PTGX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,020,486
+$309,634 QoQ
Shares Held
16,483
+1.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#143
of 343 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $65,105,395 across 33 Biotechnology names. PTGX ranks #12 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,685 | $10,771,590 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,798 | $5,485,904 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
129,836 | $4,594,896 | |
| 4 | EXEL |
Exelixis, Inc.
|
72,447 | $3,941,841 | |
| 5 | CYTK |
Cytokinetics Inc
|
38,651 | $3,292,678 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
40,203 | $3,276,946 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
55,287 | $3,163,522 | |
| 8 | MRNA |
Moderna, Inc.
|
40,868 | $2,861,986 |
All Filings in PTGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,020,486 | 16,483 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,710,852 | 16,232 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,421,982 | 16,281 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,224,039 | 18,426 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,293,539 | 23,404 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,080,217 | 22,337 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $884,634 | 22,918 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,045,800 | 23,240 | Shares | Sole | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||